Profile data is unavailable for this security.
About the company
Alibaba Health Information Technology Ltd is an investment holding company mainly engaged in the provision of Internet solutions for the medical and pharmaceutical industry, and is Alibaba Group’s healthcare flagship platform. The Company is mainly involved in the development of pharmaceutical and healthcare product and service sales business, the operation of pharmaceutical e-commerce platform and consumer healthcare services platform, the development of tracking and digital health business and Internet healthcare business using technologies such as cloud computing and big data.
- Revenue in HKD (TTM)30.48bn
- Net income in HKD1.30bn
- Incorporated1998
- Employees1.42k
- LocationAlibaba Health Information Technology Ltd26/F,Tower One, Times Square, 1 Matheson Stre Hong KongHKG
- Phone+852 25839333
- Fax+852 22155200
- Websitehttps://www.alihealth.cn/
More ▼
Mergers & acquisitions
| Acquired company | 241:HKG since announced | Transaction value |
|---|---|---|
| AJK Technology Holding Ltd | -19.14% | 1.78bn |
Data delayed at least 15 minutes, as of Nov 21 2024 08:08 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Welcia Holdings Co Ltd | 61.94bn | 1.10bn | 19.61bn | 15.29k | 17.61 | 1.56 | 8.51 | 0.3165 | 106.05 | 106.05 | 5,982.48 | 1,194.41 | 2.11 | 6.31 | 17.08 | 80,917,640.00 | 3.67 | 5.76 | 6.63 | 10.23 | 30.23 | 30.81 | 1.74 | 2.51 | 0.6511 | 38.94 | 0.2343 | 23.97 | 6.38 | 9.33 | -2.14 | 8.71 | 2.59 | 10.12 |
| Dashenlin Pharmaceutical Group Co Ltd | 28.51bn | 913.34m | 19.89bn | 45.47k | 21.84 | 2.70 | -- | 0.6978 | 0.7445 | 0.7445 | 23.37 | 6.03 | 1.12 | 4.14 | 23.28 | 583,716.30 | 3.90 | 6.57 | 8.15 | 12.63 | 33.80 | 37.51 | 3.47 | 5.54 | 0.598 | 7.15 | 0.5981 | 45.67 | 15.45 | 22.59 | 12.63 | 17.02 | 26.51 | 6.85 |
| Yifeng Pharmacy Chain Co Ltd | 25.69bn | 1.64bn | 31.20bn | 39.65k | 19.04 | 2.83 | -- | 1.21 | 1.26 | 1.26 | 19.77 | 8.46 | 0.9734 | 4.00 | 14.51 | 603,225.00 | 6.72 | 6.93 | 12.76 | 12.47 | 38.47 | 38.73 | 6.90 | 6.71 | 0.8771 | 34.97 | 0.5237 | 26.56 | 13.59 | 26.72 | 11.57 | 27.66 | 25.93 | 33.54 |
| MatsukiyoCocokara & Co | 52.10bn | 2.58bn | 43.30bn | 13.37k | 16.79 | 1.68 | 11.54 | 0.831 | 123.90 | 123.90 | 2,504.46 | 1,240.24 | 1.47 | 4.82 | 18.12 | 77,817,220.00 | 7.30 | 6.80 | 9.56 | 8.87 | 34.85 | 33.45 | 4.98 | 4.57 | 1.21 | -- | 0.0374 | 28.65 | 7.49 | 12.16 | 29.11 | 15.90 | 29.38 | 11.10 |
| Alibaba Hlth Infrmtn Tchnlgy Ltd | 30.48bn | 1.30bn | 61.63bn | 1.42k | 45.85 | 3.75 | 45.42 | 2.02 | 0.0835 | 0.0835 | 1.98 | 1.02 | 1.36 | 12.96 | 39.09 | 21,238,190.00 | 5.79 | 1.89 | 7.62 | 2.54 | 23.15 | 21.67 | 4.26 | 1.49 | 2.11 | -- | 0.0044 | 0.00 | 0.9847 | 39.61 | 64.93 | -- | 30.14 | -- |
| JD Health International Inc | 58.88bn | 2.81bn | 92.20bn | 3.18k | 32.42 | 1.64 | 30.22 | 1.57 | 0.8913 | 0.8913 | 18.63 | 17.57 | 0.8519 | 7.84 | 157.40 | 18,885,120.00 | 4.07 | -8.61 | 5.16 | -10.70 | 22.57 | 22.76 | 4.78 | -10.39 | 3.35 | -- | 0.0042 | -- | 14.54 | 45.64 | 463.49 | 58.38 | 95.69 | -- |
Data as of Nov 21 2024. Currency figures normalised to Alibaba Health Information Technology Ltd's reporting currency: Hong Kong Dollar HKD
8.25%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Krane Funds Advisors LLCas of 07 Nov 2024 | 279.64m | 1.74% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 213.43m | 1.33% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 185.45m | 1.15% |
| CSOP Asset Management Ltd.as of 07 Nov 2024 | 162.54m | 1.01% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 112.36m | 0.70% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 111.30m | 0.69% |
| Hang Seng Investment Management Ltd.as of 08 Nov 2024 | 95.69m | 0.60% |
| BlackRock Advisors (UK) Ltd.as of 08 Nov 2024 | 66.38m | 0.41% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 51.20m | 0.32% |
| Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 2024 | 49.82m | 0.31% |
More ▼
Data from 30 Jun 2024 - 08 Nov 2024Source: FactSet Research Systems Inc.
